S.Nijalingappa Institute of Dental Science and Research Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2014
NCT03511261
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

HKE'S S.N Institute of dental sciences & research center | H.K.E.S's S.Nijalingappa Institute of Dental Science and Research

Active Ingredients

Drugs in Phase 2 Trials (1)

curcumin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 2)

Oral Submucous Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1